Community Pharmacy England (CPE) - News updates
June 2025 Price Concessions 3rd Update
The Department of Health and Social Care (DHSC) has today (30/06/2025) confirmed the following list of price concessions for June 2025: Drug Pack size Price concession Erythromycin 250mg gastro-resistant tablets 28 £3.74 Esomeprazole 20mg gastro-resistant capsules 28 £2.99 Esomeprazole 40mg gastro-resistant capsules 28 £2.17 Ivabradine 2.5mg tablets 56 £26.22 Mefenamic acid 250mg tablets 28 £6.10 Progesterone [...] The post June 2025 Price Concessions 3rd Update appeared first on Community Pharmacy England.
Overwhelming public support for Pharmacy First service despite medicine supply issues
New research commissioned by Healthwatch England shows that public satisfaction with pharmacy services remains high a year after the NHS launched Pharmacy First, despite persistent medicine shortages that continue to disrupt patient care. In a poll of over 7,000 adults in England, 86% of those who sought help for common conditions reported a positive experience, [...] The post Overwhelming public support for Pharmacy First service despite medicine supply issues appeared first on Community Pharmacy England.
July 2025 Category M prices announced
The Drug Tariff Category M pricelist for July 2025 has been published on the NHS Business Services Authority (NHSBSA) website. Based on our analysis of the Category M price list for July 2025, Community Pharmacy England estimates there will be an overall reduction in reimbursement on like-for-like Category M medicines of approximately -£35m per quarter, [...] The post July 2025 Category M prices announced appeared first on Community Pharmacy England.
2025/26 Community Pharmacy Assurance Framework (CPAF) screening questionnaire
Pharmacy owners should soon receive confirmation from NHSBSA that the 2025/26 CPAF screening questionnaire will be available for completion from 1st July 2025. As a result of NHS regulations introduced at the end of 2020, completion of CPAF is now a requirement of the Terms of Service. Therefore, pharmacy owners must complete the screening questionnaire and, [...] The post 2025/26 Community Pharmacy Assurance Framework (CPAF) screening questionnaire appeared first on Community Pharmacy England.
Service fee advances
Community Pharmacy England recently announced that consultation fees for the Hypertension Case-Finding Service (HCFS) and the Pharmacy Contraception Service (PCS) are to be included in the advance payments issued to pharmacy owners by the NHS Business Services Authority. The first service fee advance was received on 12 May (for activity completed in April 2025) and [...] The post Service fee advances appeared first on Community Pharmacy England.
MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd)
MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd) Drug Alert Number: EL(25)A/31 Date issued: 30 June 2025 Wockhardt UK Limited is recalling the above batch as a precautionary measure following the identification of a dissolution failure during stability testing. DMRC reference number:DMRC-35980389 Marketing Authorisation Holder:Wockhardt UK Ltd Medicine Details Product name: Tamoxifen 20mg [...] The post MHRA Class 3 Medicines Recall: Tamoxifen 20mg Film-Coated Tablets (Wockhardt UK Ltd) appeared first on Community Pharmacy England.
MHRA Class 3 Medicines Recall: Omeprazole 20 mg/15 ml Oral Solution (Glenmark Pharmaceuticals Europe Ltd)
MHRA Class 3 Medicines Recall: Omeprazole 20 mg/15 ml Oral Solution (Glenmark Pharmaceuticals Europe Ltd) Drug Alert Number: EL(25)A/30 Date issued: 30 June 2025 Glenmark Pharmaceuticals Europe Ltd is recalling a specific batch of Omeprazole Oral Solution as a precautionary measure due to an investigation following a customer complaint indicating precipitation and discoloration of the product [...] The post MHRA Class 3 Medicines Recall: Omeprazole 20 mg/15 ml Oral Solution (Glenmark Pharmaceuticals Europe Ltd) appeared first on Community Pharmacy England.
Medicine Supply Notification: Betamethasone 500microgram soluble tablets sugar free
The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following product: Betamethasone 500microgram soluble tablets sugar free MSN/2025/040 Tier 2 – medium impact Date of issue: 30/06/2025 Betamethasone 500microgram soluble tablets are out of stock until late July 2025, when a limited resupply is expected; full resupply is [...] The post Medicine Supply Notification: Betamethasone 500microgram soluble tablets sugar free appeared first on Community Pharmacy England.
Medicines supply issues ‘distressing new normal’, Pressures Survey confirms
Community Pharmacy England has today released a national report demonstrating the impact of a ‘distressing new normal’ of medicines shortages on patients and community pharmacies across England. The Pharmacy Pressures Survey 2025: Medicines Supply Report shows how pharmacies and patients are paying the price in a system that seems stuck at breaking point. The report, which [...] The post Medicines supply issues ‘distressing new normal’, Pressures Survey confirms appeared first on Community Pharmacy England.
CPCF changes and future planning the focus of June Committee Meeting
Community Pharmacy England met in Liverpool, with Members considering the current political context and pressures exerting on the sector, as well as implementation of the agreed changes to the Community Pharmacy Contractual Framework (CPCF). During the meeting on 25th and 26th June 2025, updates were provided on critical economic projects and ongoing work around medicines [...] The post CPCF changes and future planning the focus of June Committee Meeting appeared first on Community Pharmacy England.